|
1
|
Van Cutsem E, Sagaert X, Topal B,
Haustermans K and Prenen H: Gastric cancer. Lancet. 388:2654–2664.
2016. View Article : Google Scholar
|
|
2
|
Cai J, Niu X, Chen Y, Hu Q, Shi G, Wu H,
Wang J and Yi J: Emodin-induced generation of reactive oxygen
species inhibits RhoA activation to sensitize gastric carcinoma
cells to anoikis. Neoplasia. 10:41–51. 2008. View Article : Google Scholar
|
|
3
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
4
|
Sun Y and Ma L: The emerging molecular
machinery and therapeutic targets of metastasis. Trends Pharmacol
Sci. 36:349–359. 2015. View Article : Google Scholar
|
|
5
|
Turajlic S and Swanton C: Metastasis as an
evolutionary process. Science. 352:169–175. 2016. View Article : Google Scholar
|
|
6
|
Tanabe S, Ishido K, Matsumoto T, Kosaka T,
Oda I, Suzuki H, Fujisaki J, Ono H, Kawata N, Oyama T, et al:
Long-term outcomes of endoscopic submucosal dissection for early
gastric cancer: A multicenter collaborative study. Gastric Cancer.
20 (Suppl 1):45–52. 2017. View Article : Google Scholar
|
|
7
|
Bang YJ, Van Cutsem E, Feyereislova A,
Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T,
et al ToGA Trial Investigators, : Trastuzumab in combination with
chemotherapy versus chemotherapy alone for treatment of
HER2-positive advanced gastric or gastro-oesophageal junction
cancer (ToGA): A phase 3, open-label, randomised controlled trial.
Lancet. 376:687–697. 2010. View Article : Google Scholar
|
|
8
|
Kang YK, Satoh T, Ryu MH, Chao Y, Kato K,
Chung HC, Chen JS, Muro K, Kang WK, Yoshikawa T, et al: Nivolumab
(ONO-4538/BMS-936558) as salvage treatment after second or
later-line chemotherapy for advanced gastric or gastro-esophageal
junction cancer (AGC): a double-blinded, randomized, phase III
trial. J Clin Oncol. 35 (Suppl 4):2. 2017. View Article : Google Scholar
|
|
9
|
Xu X, Qian LJ, Su XY, He KF, Jin KT, Gu
LH, Feng JG, Li GL, Zhou Q, Xu ZZ, et al: Establishment and
characterization of GCSR1, a multi-drug resistant signet ring cell
gastric cancer cell line. Int J Oncol. 46:2479–2487. 2015.
View Article : Google Scholar
|
|
10
|
Cheng J, Kapranov P, Drenkow J, Dike S,
Brubaker S, Patel S, Long J, Stern D, Tammana H, Helt G, et al:
Transcriptional maps of 10 human chromosomes at 5-nucleotide
resolution. Science. 308:1149–1154. 2005. View Article : Google Scholar
|
|
11
|
Birney E, Stamatoyannopoulos JA, Dutta A,
Guigó R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis
ET, Thurman RE, et al Children's Hospital Oakland Research
Institute, : Identification and analysis of functional elements in
1% of the human genome by the ENCODE pilot project. Nature.
447:799–816. 2007. View Article : Google Scholar
|
|
12
|
Carninci P, Kasukawa T, Katayama S, Gough
J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, et al
Consortium F; RIKEN Genome Exploration Research Group and Genome
Science Group, : (Genome Network Project Core Group) The
transcriptional landscape of the mammalian genome. Science.
309:1559–1563. 2005. View Article : Google Scholar
|
|
13
|
Geisler S and Coller J: RNA in unexpected
places: Long non-coding RNA functions in diverse cellular contexts.
Nat Rev Mol Cell Biol. 14:699–712. 2013. View Article : Google Scholar
|
|
14
|
Hirakata S and Siomi MC: piRNA biogenesis
in the germline: From transcription of piRNA genomic sources to
piRNA maturation. Biochim Biophys Acta. 1859:82–92. 2016.
View Article : Google Scholar
|
|
15
|
Jacquier A: The complex eukaryotic
transcriptome: Unexpected pervasive transcription and novel small
RNAs. Nat Rev Genet. 10:833–844. 2009. View
Article : Google Scholar
|
|
16
|
Kim VN, Han J and Siomi MC: Biogenesis of
small RNAs in animals. Nat Rev Mol Cell Biol. 10:126–139. 2009.
View Article : Google Scholar
|
|
17
|
Clark MB, Choudhary A, Smith MA, Taft RJ
and Mattick JS, Taft RJ and Mattick JS: The dark matter rises: The
expanding world of regulatory RNAs. Essays Biochem. 54:1–16. 2013.
View Article : Google Scholar
|
|
18
|
Li H, Hong J and Wijayakulathilaka WS:
Long non-coding RNA SNHG4 promotes cervical cancer progression
through regulating c-Met via targeting miR-148a-3p. Cell Cycle.
18:3313–3324. 2019. View Article : Google Scholar
|
|
19
|
Chen X, Chen Z, Yu S, Nie F, Yan S, Ma P,
Chen Q, Wei C, Fu H, Xu T, et al: Long noncoding RNA LINC01234
functions as a competing endogenous RNA to regulate CBFB expression
by sponging miR-204-5p in gastric cancer. Clin Cancer Res.
24:2002–2014. 2018. View Article : Google Scholar
|
|
20
|
In H, Solsky I, Palis B, Langdon-Embry M,
Ajani J and Sano T: Validation of the 8th edition of the AJCC TNM
staging system for gastric cancer using the national cancer
database. Ann Surg Oncol. 24:3683–3691. 2017. View Article : Google Scholar
|
|
21
|
Nagy Á, Lánczky A, Menyhárt O and Győrffy
B: Validation of miRNA prognostic power in hepatocellular carcinoma
using expression data of independent datasets. Sci Rep. 8:92272018.
View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Guarino M: Epithelial-mesenchymal
transition and tumour invasion. Int J Biochem Cell Biol.
39:2153–2160. 2007. View Article : Google Scholar
|
|
24
|
Romeo E, Caserta CA, Rumio C and Marcucci
F: The vicious cross-talk between tumor cells with an EMT phenotype
and cells of the immune system. Cells. 8:82019. View Article : Google Scholar
|
|
25
|
Thiery JP: Epithelial-mesenchymal
transitions in development and pathologies. Curr Opin Cell Biol.
15:740–746. 2003. View Article : Google Scholar
|
|
26
|
Wheelock MJ, Shintani Y, Maeda M, Fukumoto
Y and Johnson KR: Cadherin switching. J Cell Sci. 121:727–735.
2008. View Article : Google Scholar
|
|
27
|
Nishizuka M, Komada R and Imagawa M:
Knockdown of RhoE expression enhances TGF-β-induced EMT
(epithelial-to-mesenchymal transition) in cervical cancer HeLa
cells. Int J Mol Sci. 20:202019. View Article : Google Scholar
|
|
28
|
Zhou J, Cheng H, Wang Z, Chen H, Suo C,
Zhang H, Zhang J, Yang Y, Geng L, Gu M, et al: Bortezomib
attenuates renal interstitial fibrosis in kidney transplantation
via regulating the EMT induced by TNF-α-Smurf1-Akt-mTOR-P70S6K
pathway. J Cell Mol Med. 23:5390–5402. 2019. View Article : Google Scholar
|
|
29
|
Xu R, Feng F, Yu X, Liu Z and Lao L:
LncRNA SNHG4 promotes tumour growth by sponging miR-224-3p and
predicts poor survival and recurrence in human osteosarcoma. Cell
Prolif. 51:e125152018. View Article : Google Scholar
|
|
30
|
Tang Y, Wu L, Zhao M, Zhao G, Mao S, Wang
L, Liu S and Wang X: LncRNA SNHG4 promotes the proliferation,
migration, invasiveness, and epithelial-mesenchymal transition of
lung cancer cells by regulating miR-98-5p. Biochem Cell Biol.
97:767–776. 2019. View Article : Google Scholar
|
|
31
|
Bian Z, Jin L, Zhang J, Yin Y, Quan C, Hu
Y, Feng Y, Liu H, Fei B, Mao Y, et al: LncRNA-UCA1 enhances cell
proliferation and 5-fluorouracil resistance in colorectal cancer by
inhibiting miR-204-5p. Sci Rep. 6:238922016. View Article : Google Scholar
|
|
32
|
Yin Y, Zhang B, Wang W, Fei B, Quan C,
Zhang J, Song M, Bian Z, Wang Q, Ni S, et al: miR-204-5p inhibits
proliferation and invasion and enhances chemotherapeutic
sensitivity of colorectal cancer cells by downregulating RAB22A.
Clin Cancer Res. 20:6187–6199. 2014. View Article : Google Scholar
|
|
33
|
Liu L, Wang J, Li X, Ma J, Shi C, Zhu H,
Xi Q, Zhang J, Zhao X and Gu M: MiR-204-5p suppresses cell
proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma.
Biochem Biophys Res Commun. 457:621–626. 2015. View Article : Google Scholar
|
